X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (10) 10
female (8) 8
cancer (7) 7
index medicus (6) 6
medicine, general & internal (5) 5
oncology (5) 5
anemia (4) 4
care and treatment (4) 4
abridged index medicus (3) 3
aged (3) 3
breast neoplasms - drug therapy (3) 3
chemotherapy (3) 3
câncer (3) 3
drug therapy, combination (3) 3
ferro (3) 3
health aspects (3) 3
iron (3) 3
male (3) 3
analysis (2) 2
antineoplastic agents - therapeutic use (2) 2
antineoplastic agents, hormonal - therapeutic use (2) 2
apoptosis (2) 2
cancer therapies (2) 2
cell lung-cancer (2) 2
clinical trials (2) 2
goserelin - therapeutic use (2) 2
immunotherapy (2) 2
latin america (2) 2
metastasis (2) 2
middle aged (2) 2
mortality (2) 2
neoplasms - complications (2) 2
neoplasms - drug therapy (2) 2
nitriles - therapeutic use (2) 2
premenopause (2) 2
prevention (2) 2
research (2) 2
tamoxifen - therapeutic use (2) 2
triazoles - therapeutic use (2) 2
acetic acid (1) 1
acid-base equilibrium (1) 1
activated macrophages (1) 1
adjuvant treatment (1) 1
adult (1) 1
analgesics (1) 1
anaplastic oligodendroglioma (1) 1
anemia - chemically induced (1) 1
anemia - drug therapy (1) 1
animals (1) 1
anthracyclines (1) 1
anti-erbb2 antibodies (1) 1
anti-idiotypic antibodies (1) 1
anti-obesity agents - adverse effects (1) 1
antibodies, monoclonal - administration & dosage (1) 1
antibodies, monoclonal - adverse effects (1) 1
antibodies, monoclonal - therapeutic use (1) 1
antibodies, monoclonal, humanized (1) 1
antibodies, monoclonal, humanized - administration & dosage (1) 1
antigens (1) 1
antineoplastic agents - administration & dosage (1) 1
antineoplastic agents - adverse effects (1) 1
antineoplastic agents, immunological - administration & dosage (1) 1
antineoplastic agents, immunological - adverse effects (1) 1
antineoplastic agents, phytogenic - administration & dosage (1) 1
antineoplastic combined chemotherapy protocols (1) 1
aromatase inhibitors - therapeutic use (1) 1
bevacizumab (1) 1
blood tranfusion (1) 1
blood transfusion (1) 1
blood-transfusion (1) 1
bone density conservation agents - therapeutic use (1) 1
brain neoplasms (1) 1
breast cancer (1) 1
breast-cancer (1) 1
breast-cancer cells (1) 1
cancer patients (1) 1
carboplatin (1) 1
carboplatin - administration & dosage (1) 1
carboplatin - adverse effects (1) 1
carcinoembryonic antigen (1) 1
carcinoembryonic antigen - blood (1) 1
caribbean region (1) 1
cba/j mice (1) 1
cells, cultured (1) 1
cervical cancer (1) 1
cervical-cancer (1) 1
cervix uteri - pathology (1) 1
cetose (1) 1
chemotherapy, adjuvant (1) 1
chemotherapy-related anemia (1) 1
choque séptico/terapia (1) 1
cisplatin (1) 1
cisplatin - administration & dosage (1) 1
cisplatin - adverse effects (1) 1
clinical medicine (1) 1
clinical trials as topic (1) 1
cloro (1) 1
cluster-randomized trial (1) 1
colon cancer (1) 1
colonic neoplasms - blood (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 14, pp. 1405 - 1438
Journal Article
Future Oncology, ISSN 1479-6694, 04/2011, Volume 7, Issue 4, pp. 507 - 517
Cancer-related anemia adversely affects quality of life and is associated with reduced overall survival. The correction of anemia in cancer patients has the... 
iron | cancer | anemia | erythropoiesis-stimulating agents | blood tranfusion | RECOMBINANT-HUMAN-ERYTHROPOIETIN | INTRAVENOUS IRON | CHEMOTHERAPY-RELATED ANEMIA | EVERY 3 WEEKS | STIMULATING AGENTS | ONCOLOGY | EPOETIN-BETA | DOUBLE-BLIND | BLOOD-TRANSFUSION | PLACEBO-CONTROLLED TRIAL | DARBEPOETIN-ALPHA
Journal Article
Journal Article
by Paz-Ares, Luis and Dvorkin, Mikhail and Chen, Chengshui and Chen, Yen-Hsun and Chen, Yuan and Chen, Yuanbin and Chen, Zhendong and Reinmuth, Niels and Hotta, Katsuyuki and Trukhin, Dmytro and Statsenko, Galina and Hochmair, Maximilian J and Özgüroğlu, Mustafa and Ji, Jun Ho and Voitko, Nataliia and Voitko, Oleksandr and Poltoratskiy, Artem and Ponce, Santiago and Verderame, Francesco and Havel, Libor and Bondarenko, Igor and Kazarnowicz, Andrzej and Losonczy, György and Conev, Nikolay V and Armstrong, Jon and Byrne, Natalie and Shire, Norah and Jiang, Haiyi and Goldman, Jonathan W and Batagelj, Emilio and Casarini, Ignacio and Pastor, Anea Viviana and Sena, Susana Noemi and Zarba, Juan Jose and Burghuber, Otto and Hartl, Sylvia and Lamprecht, Bernd and Studnicka, Michael and Alberto Schlittler, Luis and Augusto Martinelli de Oliveira, Fabricio and Calabrich, Aknar and Colagiovanni Girotto, Gustavo and Dos Reis, Peo and Fausto Nino Gorini, Carlos and Rafael Martins De Marchi, Peo and Serodio da Rocha Baldotto, Clarissa and Sette, Claudia and Zukin, Mauro and Dudov, Assen and Ilieva, Rumyana and Koynov, Krassimir and Krasteva, Rositsa and Tonev, Ivan and Valev, Spartak and Venkova, Violetka and Bi, Minghong and Fang, Jian and Feng, Jifeng and Han, Zhigang and Hu, Jie and Hu, Yi and Li, Wei and Li, Chien-Te and Liang, Zongan and Lin, Zhong and Ma, Shenglin and Ma, Rui and Nan, Kejun and Shu, Yongqian and Wang, Chin-Chou and Wang, Kai and Wang, Mengzhao and Wu, Gang and Wu, Shang-Yin and Yang, Nong and Yang, Zhixiong and Zhang, Wei and Zhang, Helong and Zhao, Yanqiu and Zhao, Jun and Zhou, Jianying and Zhou, Caicun and Zhou, Xiangdong and Kolek, Vitezslav and Koubkova, Leona and Roubec, Jaromir and Skrickova, Jana and Zemanova, Milada and Chouaid, Christos and Hilgers, Werner and Lena, Hervé and Moro-Sibilot, Denis and Robinet, Gilles and Souquet, Pierre-Jean and Alt, Jürgen and Bischoff, Helge and Grohe, Christian and Laack, Eckart and Lang, Susanne and Panse, Jens and ... and CASPIAN Investigators and CASPIAN investigators
The Lancet, ISSN 0140-6736, 11/2019, Volume 394, Issue 10212, pp. 1929 - 1939
Most patients with small-cell lung cancer (SCLC) have extensive-stage disease at presentation, and prognosis remains poor. Recently, immunotherapy has... 
PROPHYLACTIC CRANIAL IRRADIATION | SCLC | MEDICINE, GENERAL & INTERNAL | METAANALYSIS | CISPLATIN | Antineoplastic Agents, Immunological - administration & dosage | Lung Neoplasms - drug therapy | Etoposide - adverse effects | Drug Administration Schedule | Lung Neoplasms - mortality | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols | Carboplatin - administration & dosage | Etoposide - administration & dosage | Male | Small Cell Lung Carcinoma - drug therapy | Cisplatin - administration & dosage | Carboplatin - adverse effects | Antineoplastic Agents, Immunological - adverse effects | Antineoplastic Agents, Phytogenic - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Antibodies, Monoclonal - administration & dosage | Progression-Free Survival | Cisplatin - adverse effects | Female | Small Cell Lung Carcinoma - mortality | Aged | Etoposide | Care and treatment | Product development | Lung cancer | Analysis | Drugs | Medical services | Radiation | Clinical trials | Metastasis | Cancer therapies | Randomization | Motivation | Platinum | Immunotherapy | Safety | Neutropenia | Small cell lung carcinoma | Maintenance | Radiation therapy | Survival | Patients | Cisplatin | Response rates | Carboplatin | Irradiation | Ligands | Clinical medicine | Solid tumors | Tumors | Apoptosis
Journal Article
ONCOLOGY, ISSN 0890-9091, 03/2008, Volume 22, Issue 3, pp. 260 - 270
The use of adjuvant chemotherapy following resection for all patients with stage III colon cancer is now part of the standard of care around the world. Recent... 
Colonic Neoplasms - surgery | Organoplatinum Compounds - administration & dosage | Colonic Neoplasms - drug therapy | Colonic Neoplasms - pathology | Humans | Clinical Trials as Topic | Antineoplastic Agents - administration & dosage | Chemotherapy, Adjuvant | Neoplasm Staging
Journal Article
Future oncology (London, England), 04/2011, Volume 7, Issue 4, p. 507
Cancer-related anemia adversely affects quality of life and is associated with reduced overall survival. The correction of anemia in cancer patients has the... 
Neoplasms - complications | Anemia - drug therapy | Hematinics - therapeutic use | Antineoplastic Agents - adverse effects | Humans | Anemia - chemically induced | Hematinics - adverse effects | Neoplasms - blood supply | Neoplasms - radiotherapy | Antineoplastic Agents - therapeutic use | Neoplasms - drug therapy
Journal Article
Revista Brasileira de Hematologia e Hemoterapia, ISSN 1516-8484, 2010, Volume 32, Issue 2, pp. 95 - 98
O desenvolvimento de anemia é bastante frequente nos pacientes com câncer. Geralmente é decorrente de diversos fatores, sendo a deficiência de ferro um... 
Anemia | Iron | Cancer | MEDICINE, RESEARCH & EXPERIMENTAL | HEMATOLOGY
Journal Article
Revista Brasileira de Hematologia e Hemoterapia, ISSN 1516-8484, 06/2010, Volume 32, pp. 84 - 88
Journal Article
Revista Brasileira de Hematologia e Hemoterapia, ISSN 1516-8484, 06/2010, Volume 32, pp. 84 - 88
O desenvolvimento de anemia é bastante frequente nos pacientes com câncer. Geralmente é decorrente de diversos fatores, sendo a deficiência de ferro um... 
iron | cancer | Anemia | câncer | ferro
Journal Article
Journal Article
Case Reports in Oncology, ISSN 1662-6575, 03/2009, Volume 2, Issue 1, pp. 57 - 60
In this case report, we describe a rare case of a 32-year-old man who presented a highly aggressive, fast growing anaplastic oligodendroglioma five years after... 
Published: March 2009 | Targeted therapies | Brain neoplasms | Temozolomide | Anaplastic oligodendroglioma | Bevacizumab
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.